Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comprehensive Assessment of Cancer Theranostic Response
Sponsor: AIQ Solutions
Summary
The intent of this study is to evaluate actionable outputs from TRAQinform Theranostics in a prospective, multi-center, non-interventional clinical study. The primary objective is to investigate intent-to-change treatment decisions after the addition of TRAQinform Theranostics. The exploratory objective is to investigate if treatment efficacy and treatment-related toxicity could be detected by TRAQinform Theranostics following PSMA PET/CT at week 12.
Official title: Comprehensive Assessment of Cancer Theranostic Response; Investigating the Intent to Change Treatment Decisions Based on TRAQinform Theranostics
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2024-12-02
Completion Date
2026-05-29
Last Updated
2025-09-09
Healthy Volunteers
No
Conditions
Interventions
TRAQinform Theranostics
This prospective, multi-center, non-interventional clinical study will evaluate actionable outputs from TRAQinform Theranostics, a software only medical device that identifies, quantifies, tracks, and compares lesions between different imaging modalities and multiple imaging timepoints.
Locations (2)
Weill Medical College of Cornell
New York, New York, United States
M.D. Anderson Cancer Center
Houston, Texas, United States